Atherothrombosis in Atherosclerosis: When Healing Becomes Harm
The word thrombosis carries an almost universally negative connotation in medicine. A clot, in popular understanding, is something that blocks, damages, and kills. In the context of atherosclerosis, this understanding is dangerously incomplete. Before a thrombus becomes a catastrophe, it is often something else entirely: a repair mechanism, a biological emergency response, the body's attempt to seal a breach and rebuild what was lost.
Understanding this distinction — between atherothrombosis as a constructive process and atherothrombosis as a destructive one — is not merely of academic interest. It has direct consequences for how we intervene, and how we sometimes cause harm while intending to help.
The biology of repair
Atherosclerotic plaques are not static structures. They accumulate over years, build fibrous caps, and in many people remain clinically silent throughout an entire lifetime. Pathological studies of elderly individuals who died without cardiovascular events regularly reveal plaques in various stages of healing — scarred, re-endothelialized, covered by organized thrombi. The body had been managing these plaques, repairing disruptions, and rebuilding protective surfaces continuously and silently.
When a plaque surface is disrupted — when its endothelial cap tears or erodes — the exposed underlying material triggers an immediate thrombotic response. Platelets, activated through their glycoprotein integrin receptors, adhere to the damaged surface. Fibrinogen, often misread purely as a marker of coagulation abnormality, participates actively in this repair: it serves as scaffolding through which inflammatory cells migrate from the bloodstream, differentiate into mature forms, and begin constructing a new protective cap. Under favorable conditions, a connective tissue scar forms, covered with fresh endothelium, and the plaque is sealed again. The thrombus was never the problem. It was the solution.
This is atherothrombosis in its constructive phase: a localized, wall-adherent, temporary biological structure whose purpose is re-endothelialization and repair.
When repair becomes danger
The transition from constructive to destructive atherothrombosis is not inevitable. It depends on conditions. When thrombus formation is disrupted — when adhesion to the damaged vascular wall is poor, when the clot becomes friable rather than firmly organized, when the process that should be local and temporary instead propagates or embolizes — the repair mechanism becomes the source of the very events it was designed to prevent. The thrombus loses its temporary function. Instead of rebuilding the cap, it threatens the lumen. Fragments break off. Downstream ischemia follows. What was healing becomes catastrophe.
Elevated fibrinogen in this context should be read not simply as a risk marker but as a signal about the quality and stability of ongoing repair processes in disrupted plaques. The concern is not fibrin formation itself. The concern is disturbance within that formation.
The danger of uninformed intervention
This is where clinical humility becomes essential. Many pharmacological interventions targeting coagulation, platelet function, or inflammation are designed with the destructive phase in mind — the thrombosis that occludes, embolizes, and kills. But applied without sufficient understanding of the biological context, these same interventions can interfere with the constructive phase: disrupting the organized, wall-adherent thrombus that is actively repairing a damaged plaque surface, converting a stable repair process into an unstable one.
Atherosclerosis is not unique in this respect. It is one example of a broader principle that governs all healing in living systems: biological repair processes have their own logic, their own timing, and their own conditions for success. An intervention that interrupts or distorts those conditions — however well-intentioned — can transform what the body was doing constructively into something destructive. The history of medicine contains many such examples, and atherothrombosis is among the most consequential.
This does not argue against intervention. It argues for accurate intervention — one that begins with understanding what the biological process is actually doing before deciding what to change. When a thrombus forms over a disrupted plaque, the first question should not be how to dissolve it, but whether it is doing its job. If it is firmly adherent, locally contained, and progressing toward re-endothelialization, the clinical task may be to support those conditions rather than to interrupt them.
The body's repair systems evolved over millions of years. They are not infallible, and they sometimes fail in ways that require urgent correction. But they are also not the enemy. In atherothrombosis as in all healing, the clinician's deepest obligation is to understand the process well enough to know when to act and when, with equal wisdom, to stand aside.
What's new about this idea
What has clear precedents
The basic observation that thrombosis serves a repair function is not new. Virchow's triad — describing the conditions for pathological clot formation — implicitly acknowledged that coagulation is a normal physiological process that becomes dangerous under specific conditions. The concept of plaque healing and re-endothelialization after disruption has been present in pathological literature since at least the 1980s and 1990s, associated with researchers like Michael Davies and Erling Falk who described the natural history of plaque rupture and healing in autopsy studies.
The observation that many elderly people die with healed plaques — evidence of repeated disruption and repair without clinical events — is well documented in pathological literature and is not original to this text.
What is genuinely original in this framing
Several things distinguish this text from the standard presentation of atherothrombosis.
The explicit reframing of atherothrombosis as primarily a constructive and reparative process that becomes destructive only under specific conditions — rather than as an intrinsically pathological event — is stated with unusual clarity and directness. Most cardiology textbooks and guidelines present atherothrombosis almost exclusively in its destructive form. The constructive phase is acknowledged in specialized pathology literature but rarely emphasized in clinical teaching or practice.
The reinterpretation of fibrinogen as primarily a marker and participant of reparative activity rather than simply a coagulation abnormality or cardiovascular risk factor is conceptually important and underrepresented in clinical literature. Standard guidelines treat elevated fibrinogen as a risk marker without this nuance.
Most significantly — the explicit warning that pharmacological interventions can convert constructive atherothrombosis into destructive atherothrombosis by disrupting organized repair processes is genuinely underrepresented in clinical literature. The possibility that antiplatelet and anticoagulant therapies might in some contexts interfere with beneficial plaque healing is occasionally discussed in specialized research but almost never framed this clearly as a clinical principle requiring active awareness.
The broader philosophical principle — that accurate intervention requires understanding what the biological process is doing before deciding to interrupt it — applied specifically to atherothrombosis is original in its directness and clinical implications.
How it stands in current science
Recent research has begun moving in a direction that supports this framing. The concept of plaque erosion as distinct from rupture — where thrombus forms over an intact but damaged endothelium and may heal without intervention — has generated genuine debate about whether aggressive antithrombotic therapy is always appropriate. A 2019 study published in the European Heart Journal suggested that some patients with plaque erosion rather than rupture might be managed with less aggressive intervention than current guidelines recommend. This is exactly the clinical territory this text is pointing toward.
The principle of disease optimality — that disease processes follow their own adaptive logic and that intervention should work with rather than against that logic — is the conceptual foundation of this text and is not standard in cardiovascular medicine, where the dominant paradigm remains one of aggressive suppression of the thrombotic process.
Overall assessment
The individual observations have precedents. The synthesis — constructive versus destructive atherothrombosis, fibrinogen as a repair marker, the danger of uninformed intervention converting repair into harm, and the broader principle of accurate intervention in biological healing — presented as a unified clinical and philosophical framework is genuinely original and clinically important.
It belongs in the conversation alongside the emerging literature on plaque erosion and conservative management, and it anticipates directions that cardiovascular medicine is only beginning to move toward. .
You can learn more by reading our e-book or listening to our audiobook
Mykola Iabluchanskyi (Yabluchansky)
Comments